Therapeutic Advances in Gastroenterology

SJR Rank #4,048H-index: 77SJR: 1.123Best quartile: Q1Open AccessAPC: US$2,700Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

SAGE Publications Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.350.71.051.4

Subject Categories

  • GastroenterologyQ1

Areas: Medicine

Most published research topics

Inflammatory Bowel DiseaseMicroscopic ColitisGastrointestinal motility and disordersHelicobacter pylori-related gastroenterology studiesColorectal Cancer Screening and DetectionGastric Cancer Management and OutcomesGastroesophageal reflux and treatmentsClostridium difficile and Clostridium perfringens researchGut microbiota and healthGastrointestinal Bleeding Diagnosis and Treatment

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025060120180240

Detailed Information

ISSN

1756-283X, 1756-2848

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

3.85

References per Document

44.73

Coverage

2008-2026

Scope

Therapeutic Advances in Gastroenterology is an open access journal which delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of gastrointestinal and hepatic disorders. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in gastroenterology and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area. The editors welcome original research articles across all areas of gastroenterology and hepatology. The journal publishes original research articles and review articles primarily. Original research manuscripts may include laboratory, animal or human/clinical studies – all phases. Letters to the Editor and Case Reports will also be considered.

Metrics from SCImago Journal Rank 2025. View on SCImago